Towards Safe and Effective Hematopoietic Stem Cell Gene Therapy: Targeting Integration to Genomic Safe Harbors and Exploiting Endogenous microRNA to Regulate Transgene Expression

Projektinformationen

TARGETINGGENETHERAPY

ID Finanzhilfevereinbarung: 249845

Projekt abgeschlossen

Startdatum 1 Mai 2010

Enddatum 31 Januar 2016

Finanziert unter

• Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Gesamtkosten € 2 500 000,00

EU-Beitrag € 2 500 000,00

Koordiniert durch

UNIVERSITA VITA-SALUTE SAN RAFFAELE
Italy